Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?

Christian S. Shinaberger, Sander Greenland, Joel D. Kopple, David Van Wyck, Rajnish Mehrotra, Csaba Kovesdy, Kamyar Kalantar-Zadeh

Research output: Contribution to journalArticle

202 Citations (Scopus)

Abstract

Background: Dietary restrictions to control serum phosphorus, which are routinely recommended to persons with chronic kidney disease, are usually associated with a reduction in protein intake. This may lead to protein-energy wasting and poor survival. Objective: We aimed to ascertain whether a decline in serum phosphorus and a concomitant decline in protein intake are associated with an increase in the risk of death. Design: In a 3-y study (7/2001-6/2004) of 30 075 prevalent maintenance hemodialysis (MHD) patients, we examined changes in serum phosphorus and in normalized protein nitrogen appearance (nPNA), a surrogate of dietary protein intake, during the first 6 mo and the subsequent mortality. Four groups of MHD patients were defined on the basis of the direction of the changes in serum phosphorus and nPNA. Results: Baseline phosphorus had a J-shaped association with mortality, whereas higher baseline nPNA was linearly associated with greater survival. Compared with MHD patients whose serum phosphorus and nPNA both rose over 6 mo, those whose serum phosphorus decreased but whose nPNA increased had greater survival, with a case mix-adjusted death risk ratio of 0.90 (95% confidence limits: 0.86, 0.95; P < 0.001), whereas those whose phosphorus increased but whose nPNA decreased or those whose phosphorus and nPNA both decreased had worse mortality with a risk ratio of 1.11 (1.05,1.17; P < 0.001) and 1.06 (1.01,1.12; P = 0.02), respectively. Conclusions: The risk of controlling serum phosphorus by restricting dietary protein intake may outweigh the benefit of controlled phosphorus and may lead to greater mortality. Additional studies including randomized controlled trials should examine whether non-dietary control of phosphorus or restriction of nonprotein sources of phosphorus is safer and more effective.

Original languageEnglish (US)
Pages (from-to)1511-1518
Number of pages8
JournalAmerican Journal of Clinical Nutrition
Volume88
Issue number6
DOIs
StatePublished - Dec 1 2008
Externally publishedYes

Fingerprint

Dietary Proteins
Chronic Renal Insufficiency
Phosphorus
Nitrogen
Proteins
Serum
Renal Dialysis
Mortality
Survival
Odds Ratio
Diagnosis-Related Groups
Randomized Controlled Trials

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? / Shinaberger, Christian S.; Greenland, Sander; Kopple, Joel D.; Van Wyck, David; Mehrotra, Rajnish; Kovesdy, Csaba; Kalantar-Zadeh, Kamyar.

In: American Journal of Clinical Nutrition, Vol. 88, No. 6, 01.12.2008, p. 1511-1518.

Research output: Contribution to journalArticle

Shinaberger, Christian S. ; Greenland, Sander ; Kopple, Joel D. ; Van Wyck, David ; Mehrotra, Rajnish ; Kovesdy, Csaba ; Kalantar-Zadeh, Kamyar. / Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?. In: American Journal of Clinical Nutrition. 2008 ; Vol. 88, No. 6. pp. 1511-1518.
@article{00ead525652443e29f99d8eccaa251e0,
title = "Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?",
abstract = "Background: Dietary restrictions to control serum phosphorus, which are routinely recommended to persons with chronic kidney disease, are usually associated with a reduction in protein intake. This may lead to protein-energy wasting and poor survival. Objective: We aimed to ascertain whether a decline in serum phosphorus and a concomitant decline in protein intake are associated with an increase in the risk of death. Design: In a 3-y study (7/2001-6/2004) of 30 075 prevalent maintenance hemodialysis (MHD) patients, we examined changes in serum phosphorus and in normalized protein nitrogen appearance (nPNA), a surrogate of dietary protein intake, during the first 6 mo and the subsequent mortality. Four groups of MHD patients were defined on the basis of the direction of the changes in serum phosphorus and nPNA. Results: Baseline phosphorus had a J-shaped association with mortality, whereas higher baseline nPNA was linearly associated with greater survival. Compared with MHD patients whose serum phosphorus and nPNA both rose over 6 mo, those whose serum phosphorus decreased but whose nPNA increased had greater survival, with a case mix-adjusted death risk ratio of 0.90 (95{\%} confidence limits: 0.86, 0.95; P < 0.001), whereas those whose phosphorus increased but whose nPNA decreased or those whose phosphorus and nPNA both decreased had worse mortality with a risk ratio of 1.11 (1.05,1.17; P < 0.001) and 1.06 (1.01,1.12; P = 0.02), respectively. Conclusions: The risk of controlling serum phosphorus by restricting dietary protein intake may outweigh the benefit of controlled phosphorus and may lead to greater mortality. Additional studies including randomized controlled trials should examine whether non-dietary control of phosphorus or restriction of nonprotein sources of phosphorus is safer and more effective.",
author = "Shinaberger, {Christian S.} and Sander Greenland and Kopple, {Joel D.} and {Van Wyck}, David and Rajnish Mehrotra and Csaba Kovesdy and Kamyar Kalantar-Zadeh",
year = "2008",
month = "12",
day = "1",
doi = "10.3945/ajcn.2008.26665",
language = "English (US)",
volume = "88",
pages = "1511--1518",
journal = "American Journal of Clinical Nutrition",
issn = "0002-9165",
publisher = "American Society for Nutrition",
number = "6",

}

TY - JOUR

T1 - Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?

AU - Shinaberger, Christian S.

AU - Greenland, Sander

AU - Kopple, Joel D.

AU - Van Wyck, David

AU - Mehrotra, Rajnish

AU - Kovesdy, Csaba

AU - Kalantar-Zadeh, Kamyar

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Background: Dietary restrictions to control serum phosphorus, which are routinely recommended to persons with chronic kidney disease, are usually associated with a reduction in protein intake. This may lead to protein-energy wasting and poor survival. Objective: We aimed to ascertain whether a decline in serum phosphorus and a concomitant decline in protein intake are associated with an increase in the risk of death. Design: In a 3-y study (7/2001-6/2004) of 30 075 prevalent maintenance hemodialysis (MHD) patients, we examined changes in serum phosphorus and in normalized protein nitrogen appearance (nPNA), a surrogate of dietary protein intake, during the first 6 mo and the subsequent mortality. Four groups of MHD patients were defined on the basis of the direction of the changes in serum phosphorus and nPNA. Results: Baseline phosphorus had a J-shaped association with mortality, whereas higher baseline nPNA was linearly associated with greater survival. Compared with MHD patients whose serum phosphorus and nPNA both rose over 6 mo, those whose serum phosphorus decreased but whose nPNA increased had greater survival, with a case mix-adjusted death risk ratio of 0.90 (95% confidence limits: 0.86, 0.95; P < 0.001), whereas those whose phosphorus increased but whose nPNA decreased or those whose phosphorus and nPNA both decreased had worse mortality with a risk ratio of 1.11 (1.05,1.17; P < 0.001) and 1.06 (1.01,1.12; P = 0.02), respectively. Conclusions: The risk of controlling serum phosphorus by restricting dietary protein intake may outweigh the benefit of controlled phosphorus and may lead to greater mortality. Additional studies including randomized controlled trials should examine whether non-dietary control of phosphorus or restriction of nonprotein sources of phosphorus is safer and more effective.

AB - Background: Dietary restrictions to control serum phosphorus, which are routinely recommended to persons with chronic kidney disease, are usually associated with a reduction in protein intake. This may lead to protein-energy wasting and poor survival. Objective: We aimed to ascertain whether a decline in serum phosphorus and a concomitant decline in protein intake are associated with an increase in the risk of death. Design: In a 3-y study (7/2001-6/2004) of 30 075 prevalent maintenance hemodialysis (MHD) patients, we examined changes in serum phosphorus and in normalized protein nitrogen appearance (nPNA), a surrogate of dietary protein intake, during the first 6 mo and the subsequent mortality. Four groups of MHD patients were defined on the basis of the direction of the changes in serum phosphorus and nPNA. Results: Baseline phosphorus had a J-shaped association with mortality, whereas higher baseline nPNA was linearly associated with greater survival. Compared with MHD patients whose serum phosphorus and nPNA both rose over 6 mo, those whose serum phosphorus decreased but whose nPNA increased had greater survival, with a case mix-adjusted death risk ratio of 0.90 (95% confidence limits: 0.86, 0.95; P < 0.001), whereas those whose phosphorus increased but whose nPNA decreased or those whose phosphorus and nPNA both decreased had worse mortality with a risk ratio of 1.11 (1.05,1.17; P < 0.001) and 1.06 (1.01,1.12; P = 0.02), respectively. Conclusions: The risk of controlling serum phosphorus by restricting dietary protein intake may outweigh the benefit of controlled phosphorus and may lead to greater mortality. Additional studies including randomized controlled trials should examine whether non-dietary control of phosphorus or restriction of nonprotein sources of phosphorus is safer and more effective.

UR - http://www.scopus.com/inward/record.url?scp=57449090292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57449090292&partnerID=8YFLogxK

U2 - 10.3945/ajcn.2008.26665

DO - 10.3945/ajcn.2008.26665

M3 - Article

VL - 88

SP - 1511

EP - 1518

JO - American Journal of Clinical Nutrition

JF - American Journal of Clinical Nutrition

SN - 0002-9165

IS - 6

ER -